IL-17A-话题@MedSci - 梅斯（MedSci）

#IL-17A#

34篇内容 | 1849人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1482912, encodeId=148b14829126c, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=Arthritis Rheumatol：乌司奴单抗降低银屑病关节炎血清CRP、IL-17A和IL-17F水平, objectType=article, longId=166550, objectId=e11f166550e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e11f166550e5, replyNumber=0, likeNumber=94, createdTime=2019-05-23, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e11f166550e5, moduleTitle=Arthritis Rheumatol：乌司奴单抗降低银屑病关节炎血清CRP、IL-17A和IL-17F水平, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e11f166550e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482911, encodeId=f6cf1482911ee, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=礼来的IL-17A单抗Taltz治疗非放射性轴向脊柱关节炎，III期临床试验大获成功, objectType=article, longId=164909, objectId=f4ff16490983, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4ff16490983, replyNumber=0, likeNumber=46, createdTime=2019-04-25, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4ff16490983, moduleTitle=礼来的IL-17A单抗Taltz治疗非放射性轴向脊柱关节炎，III期临床试验大获成功, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f4ff16490983)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482910, encodeId=6cfd1482910d6, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=DDS： IL-17A可以通过上皮-间质转化促进肠纤维化的发生和发展, objectType=article, longId=153891, objectId=e74a15389151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e74a15389151, replyNumber=0, likeNumber=72, createdTime=2018-11-20, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e74a15389151, moduleTitle=DDS： IL-17A可以通过上皮-间质转化促进肠纤维化的发生和发展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e74a15389151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482909, encodeId=354e14829096a, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=Arthritis Rheumatol：IL-17A抑制可减轻实验性脊柱关节炎的炎症并增加新骨形成, objectType=article, longId=153062, objectId=f5a7153062e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5a7153062e3, replyNumber=0, likeNumber=51, createdTime=2018-11-10, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5a7153062e3, moduleTitle=Arthritis Rheumatol：IL-17A抑制可减轻实验性脊柱关节炎的炎症并增加新骨形成, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f5a7153062e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482908, encodeId=7e3914829080b, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=Arthritis Rheumatol：抑制IL-17A可减轻脊柱关节炎的炎症和新骨形成, objectType=article, longId=152816, objectId=7f9a1528168e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f9a1528168e, replyNumber=0, likeNumber=96, createdTime=2018-11-07, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f9a1528168e, moduleTitle=Arthritis Rheumatol：抑制IL-17A可减轻脊柱关节炎的炎症和新骨形成, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7f9a1528168e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482907, encodeId=4dcb148290ee2, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=Arthritis Rheumatol：先天淋巴样细胞和T细胞影响幼年特发性关节炎滑膜液中检测到的IL-17A特征, objectType=article, longId=151942, objectId=8bbe1519423d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bbe1519423d, replyNumber=0, likeNumber=70, createdTime=2018-10-28, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bbe1519423d, moduleTitle=Arthritis Rheumatol：先天淋巴样细胞和T细胞影响幼年特发性关节炎滑膜液中检测到的IL-17A特征, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8bbe1519423d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482906, encodeId=dc0a148290646, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=Lancet:IL-17A单抗ixekizumab可有效改善X线轴向骨关节炎患者症状, objectType=article, longId=151699, objectId=f88a1516999f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f88a1516999f, replyNumber=0, likeNumber=82, createdTime=2018-10-25, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f88a1516999f, moduleTitle=Lancet:IL-17A单抗ixekizumab可有效改善X线轴向骨关节炎患者症状, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f88a1516999f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482905, encodeId=b4201482905a7, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=Lilly将启动IXORA-R头对头试验：比较IL-17A单抗Taltz和IL-23单抗Tremfya治疗中度至重度斑块型银屑病患者的疗效, objectType=article, longId=148645, objectId=6dae148645a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dae148645a9, replyNumber=0, likeNumber=53, createdTime=2018-09-13, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dae148645a9, moduleTitle=Lilly将启动IXORA-R头对头试验：比较IL-17A单抗Taltz和IL-23单抗Tremfya治疗中度至重度斑块型银屑病患者的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6dae148645a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482904, encodeId=a644148290475, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=Immunity：Card14基因突变促进皮肤角质细胞对IL-17A的应答诱导银屑病发生的分子机制, objectType=article, longId=142828, objectId=2d0014282805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d0014282805, replyNumber=0, likeNumber=78, createdTime=2018-07-11, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d0014282805, moduleTitle=Immunity：Card14基因突变促进皮肤角质细胞对IL-17A的应答诱导银屑病发生的分子机制, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2d0014282805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482903, encodeId=c38114829033c, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=J Ophthalmol：CYP4F2基因单核苷酸多态性和IL-17A浓度对视神经炎的影响, objectType=article, longId=138640, objectId=2b3d138640d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b3d138640d3, replyNumber=0, likeNumber=68, createdTime=2018-05-21, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b3d138640d3, moduleTitle=J Ophthalmol：CYP4F2基因单核苷酸多态性和IL-17A浓度对视神经炎的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2b3d138640d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482902, encodeId=ea7514829024d, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=Ann Rheum Dis：bimekizumab在银屑病关节炎中的双重IL-17A和IL-17F中和, objectType=article, longId=124471, objectId=c0bc1244e185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0bc1244e185, replyNumber=0, likeNumber=65, createdTime=2017-12-26, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0bc1244e185, moduleTitle=Ann Rheum Dis：bimekizumab在银屑病关节炎中的双重IL-17A和IL-17F中和, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c0bc1244e185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482901, encodeId=94d2148290186, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=Clin Exp Allergy：吸烟增加哮喘患者支气管粘膜IL-17A表达！, objectType=article, longId=100704, objectId=0b94100e04a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b94100e04a1, replyNumber=0, likeNumber=70, createdTime=2017-06-06, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b94100e04a1, moduleTitle=Clin Exp Allergy：吸烟增加哮喘患者支气管粘膜IL-17A表达！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0b94100e04a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482900, encodeId=a69f1482900ed, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=J Clin Endocrinol Metab：上海巴斯德所等揭示炎性因子IL-17A调控甲状腺相关眼病发生发展新机制, objectType=article, longId=97382, objectId=794d9e3823e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=794d9e3823e, replyNumber=0, likeNumber=135, createdTime=2017-04-29, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=794d9e3823e, moduleTitle=J Clin Endocrinol Metab：上海巴斯德所等揭示炎性因子IL-17A调控甲状腺相关眼病发生发展新机制, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=794d9e3823e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482899, encodeId=00d0148289976, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=The Lancet：单抗药物ixekizumab中和白介素IL-17A 成功治疗银屑病, objectType=article, longId=52031, objectId=a0e8520314d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0e8520314d, replyNumber=0, likeNumber=60, createdTime=2015-06-14, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0e8520314d, moduleTitle=The Lancet：单抗药物ixekizumab中和白介素IL-17A 成功治疗银屑病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a0e8520314d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482898, encodeId=6bcb14828984a, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=礼来IL-17A单抗ixekizumab银屑病关节炎III期成功, objectType=article, longId=49722, objectId=d82a49e227a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d82a49e227a, replyNumber=0, likeNumber=41, createdTime=2015-04-24, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d82a49e227a, moduleTitle=礼来IL-17A单抗ixekizumab银屑病关节炎III期成功, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d82a49e227a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482897, encodeId=b621148289edb, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=Ann Rheum Dis :抗IL-17A单克隆抗体可能用于治疗银屑病关节炎, objectType=article, longId=29532, objectId=275c29532df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=275c29532df, replyNumber=0, likeNumber=125, createdTime=2014-01-19, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=275c29532df, moduleTitle=Ann Rheum Dis :抗IL-17A单克隆抗体可能用于治疗银屑病关节炎, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=275c29532df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1482896, encodeId=e72e1482896fa, content=<a href='/topic/show?id=2443963952' target=_blank style='color:#2F92EE;'>#IL-17A#</a>, objectTitle=Nat Commun：IL-17A可用于肺癌治疗, objectType=article, longId=3655, objectId=03a33655cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03a33655cb, replyNumber=0, likeNumber=78, createdTime=2012-01-08, rootId=0, userName=12498bf3m27暂无昵称, userId=0ae57859469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03a33655cb, moduleTitle=Nat Commun：IL-17A可用于肺癌治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=03a33655cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IL-17A

2020-05-29

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

Arthritis Rheumatol：乌司奴单抗降低银屑病关节炎血清CRP、IL-17A和IL-17F水平

2019-05-23

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

礼来的IL-17A单抗Taltz治疗非放射性轴向脊柱关节炎，III期临床试验大获成功

2019-04-25

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

DDS： IL-17A可以通过上皮-间质转化促进肠纤维化的发生和发展

2018-11-20

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

Arthritis Rheumatol：IL-17A抑制可减轻实验性脊柱关节炎的炎症并增加新骨形成

2018-11-10

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

Arthritis Rheumatol：抑制IL-17A可减轻脊柱关节炎的炎症和新骨形成

2018-11-07

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

Arthritis Rheumatol：先天淋巴样细胞和T细胞影响幼年特发性关节炎滑膜液中检测到的IL-17A特征

2018-10-28

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

Lancet:IL-17A单抗ixekizumab可有效改善X线轴向骨关节炎患者症状

2018-10-25

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

Lilly将启动IXORA-R头对头试验：比较IL-17A单抗Taltz和IL-23单抗Tremfya治疗中度至重度斑块型银屑病患者的疗效

2018-09-13

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

Immunity：Card14基因突变促进皮肤角质细胞对IL-17A的应答诱导银屑病发生的分子机制

2018-07-11

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

J Ophthalmol：CYP4F2基因单核苷酸多态性和IL-17A浓度对视神经炎的影响

2018-05-21

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

Ann Rheum Dis：bimekizumab在银屑病关节炎中的双重IL-17A和IL-17F中和

2017-12-26

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

Clin Exp Allergy：吸烟增加哮喘患者支气管粘膜IL-17A表达！

2017-06-06

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

J Clin Endocrinol Metab：上海巴斯德所等揭示炎性因子IL-17A调控甲状腺相关眼病发生发展新机制

2017-04-29

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

The Lancet：单抗药物ixekizumab中和白介素IL-17A 成功治疗银屑病

2015-06-14

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

礼来IL-17A单抗ixekizumab银屑病关节炎III期成功

2015-04-24

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

Ann Rheum Dis :抗IL-17A单克隆抗体可能用于治疗银屑病关节炎

2014-01-19

12498bf3m27暂无昵称 (审核中...)

前往app查看评论内容

#IL-17A#

Nat Commun：IL-17A可用于肺癌治疗

2012-01-08

科室
- - 订阅+
  - 更多科室
工具
服务